ADAG
Price:
$1.88
Market Cap:
$83.23M
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a fully-human anti-CTLA-4 mAb that is in Phase 1 clinical trial for the treatment advanced/metastatic solid tumors; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase I clinical trial for the treatment of advanced metastatic solid tumors. It also offers ADG104, an anti-PD-L1 mAb that is in...[Read more]
Industry
Biotechnology
IPO Date
2021-02-09
Stock Exchange
NASDAQ
Ticker
ADAG
According to Adagene Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.35M. This represents a change of -67.48% compared to the average of 25.67M of the last 4 quarters.
The mean historical Enterprise Value of Adagene Inc. over the last ten years is 555.35M. The current 8.35M Enterprise Value has changed 50.28% with respect to the historical average. Over the past ten years (40 quarters), ADAG's Enterprise Value was at its highest in in the December 2020 quarter at 1.20B. The Enterprise Value was at its lowest in in the September 2022 quarter at -61497098.84.
Average
555.35M
Median
570.49M
Minimum
-58404258.22
Maximum
1.23B
Discovering the peaks and valleys of Adagene Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 21.26%
Maximum Annual Enterprise Value = 1.23B
Minimum Annual Increase = -137.43%
Minimum Annual Enterprise Value = -58404258.22
Year | Enterprise Value | Change |
---|---|---|
2023 | -3112639.68 | -94.67% |
2022 | -58404258.22 | -137.43% |
2021 | 156.04M | -84.16% |
2020 | 984.95M | -20.22% |
2019 | 1.23B | 21.26% |
The current Enterprise Value of Adagene Inc. (ADAG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
31.51M
5-year avg
462.80M
10-year avg
555.35M
Adagene Inc.’s Enterprise Value is less than Aerovate Therapeutics, Inc. (43.34M), less than Acrivon Therapeutics, Inc. Common Stock (158.62M), less than Rezolute, Inc. (248.88M), greater than AN2 Therapeutics, Inc. (8.33M), less than Anebulo Pharmaceuticals, Inc. (31.01M), less than AnaptysBio, Inc. (250.00M), less than Mineralys Therapeutics, Inc. (502.94M), less than Eliem Therapeutics, Inc. (0), less than Janux Therapeutics, Inc. (3.28B), less than PMV Pharmaceuticals, Inc. (42.60M), less than Molecular Partners AG (107.67M),
Company | Enterprise Value | Market cap |
---|---|---|
43.34M | $73.92M | |
158.62M | $198.03M | |
248.88M | $257.27M | |
8.33M | $41.83M | |
31.01M | $32.42M | |
250.00M | $425.09M | |
502.94M | $600.21M | |
0 | $342.68M | |
3.28B | $3.28B | |
42.60M | $78.14M | |
107.67M | $200.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adagene Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adagene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Adagene Inc.'s Enterprise Value?
What is the highest Enterprise Value for Adagene Inc. (ADAG)?
What is the 3-year average Enterprise Value for Adagene Inc. (ADAG)?
What is the 5-year average Enterprise Value for Adagene Inc. (ADAG)?
How does the current Enterprise Value for Adagene Inc. (ADAG) compare to its historical average?